Genmab — April 2024
-
Bio-Techne Corporation (NASDAQ: TECH) today announced the appointment of Dr. Judith Klimovsky to serve as an independent director on the Company's Board of Directors https://investors.bio-techne.com/press-releases/detail/418/bio-techne-appoints-dr-judith-klimovsky-to-board-of -Bio-Techne is a leading supplier of high quality and innovative tools for Life Science Research, Therapeutic Manufacturing and Clinical Diagnostics.
-
the new Endometrial Cancer trial with GEN1046 will not continue; due to [Enrollment challenged by availability of other treatment options] https://classic.clinicaltrials.gov/ct2/history/NCT06046274?A=10&B=11&C=merged#StudyPageTop
-
New trial - Trial to Assess the Safety and Preliminary Efficacy of GEN1055 on Malignant Solid Tumors as Monotherapy and as Combination Therapy (HexaBody-OX40) https://clinicaltrials.gov/study/NCT06391775
-
TECVAYLI available in Spain from may1 https://www.vademecum.es/noticia-240430-Disponible+en+Espa+ntilde+a+++9660+TECVAYLI+sup++reg+++sup+++teclistamab+++el+primer+anticuerpo+biespec+iacute+fico+anti++BCMA+sup++1++sup++autorizado+para+el+tratamiento+de+pacientes+triple+expuestos+con+mieloma+m+uacute+ltiple_90351
-
ADS'en har det lidt skidt lige nu - nede med 2,94%
-
Tak @Sukkeralf.... Føj det bliver kursmæssigt et laaaangt 2024
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind